NuVasive, Inc. provided preliminary revenue guidance results for the fourth quarter and full year of 2017. The company expects fourth quarter 2017 revenue to be approximately $272 million and full year 2017 revenue to be approximately $1,030 million and in line with the guidance provided on Oct. 24, 2017. The company's preliminary outlook for 2018 includes full year revenue growth in the mid-single digits over 2017 revenueresults, at least 100 basis points of expansion in non-GAAP operating margin, adjusted EBITDA now in a range of approximately $290 to $300 million, and a substantial tax savings resulting from the tax reform legislation passed late in 2017.